Disease prevention with islet autoantigens.
Eisenbarth
George S
GS
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Box B-140, Denver, CO 80262, USA. george.eisenbarth@uchsc.edu
Jasinski
Jean M
JM
D000818:Animals; D001324:Autoantigens / Q000008:administration & dosage / Q000627:therapeutic use; D015551:Autoimmunity; D018834:Chaperonin 60; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000517:prevention & control*; D004195:Disease Models, Animal; D005968:Glutamate Decarboxylase / Q000008:administration & dosage / Q000276:immunology; D006360:Heat-Shock Proteins / Q000008:administration & dosage / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D007328:Insulin / Q000008:administration & dosage / Q000276:immunology; D007515:Islets of Langerhans / Q000276:immunology*; D007527:Isoenzymes / Q000008:administration & dosage / Q000276:immunology; D051379:Mice; D010446:Peptide Fragments / Q000008:administration & dosage / Q000276:immunology; D051381:Rats
D001324:Autoantigens; D018834:Chaperonin 60; D006360:Heat-Shock Proteins; D007328:Insulin; D007527:Isoenzymes; D010446:Peptide Fragments; C097877:insulin B (9-23); C095402:peptide 277, heat shock protein 60; D005968:Glutamate Decarboxylase; C401141:glutamate decarboxylase 2